European Journal of Pharmacology · Nov 20, 2026

The evaluation of the potential application of friedelin as an alternative to estrogen in an ovariectomized rat model

By Saini R, Sharma SK, Sonkar VK et al.

Menopause is a condition where ovaries stop functioning due to a decrease in hormonal levels (estrogen). It leads to loss of fertility, hot flashes, anxiety, and vaginal dryness. It is recommended to take hormonal therapy to escape from these problems. Although hormonal therapy has some benefits, there are severe health-related risks like cardiovascular disease and ovarian cancer. These problems forced to search for safer alternatives like phytoestrogen. The objective of this study was to test the efficacy of friedelin as an estrogen. Friedelin is a plant-derived triterpenoid compound. Ovariectomized rats were given friedelin for 28 days, and after that behavioral parameters were recorded along with other analyses like serum estradiol level estimation, uterine histology, and deciduoma formation. Estradiol-driven gene expression (mRNA and protein level) was also checked, along with immunofluorescence localization; these genes were estrogen receptor alpha (ER-α), estrogen receptor beta (ER-β), complement component 3 (C3), early growth response 1(EgR1), and proliferating cell nuclear antigen (PCNA). Progesterone-like activity of friedelin was also checked. Improved behavioural responses were recorded, with significant increases in serum estradiol levels and epithelium thickness along with increased endometrial gland numbers. The significant upregulation of estrogen-responsive genes was found at the mRNA and protein levels in friedelin-treated groups. The localization of these genes was found primarily in endometrial stroma, luminal, and glandular epithelium. Deciduoma formation occurred only in the progesterone-administered group which denies friedelin’s progesterone-like activity. The friedelin showed estrogen-like activity. Further, preclinical and clinical investigations are needed to establish friedelin’s safety and efficacy for medical applications.

doi.org/10.1016/j.ejphar.2026.179594PubMed 43064283Interventions

AgingResearch.News